Related Articles
Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancer
Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first‑line treatment for Japanese patients with metastatic colorectal cancer
A PHASE-II TRIAL OF 5-FLUOROURACIL, FOLINIC ACID, VINORELBINE IN PRETREATED PATIENTS WITH METASTIC COLORECTAL-CANCER
Treatment of advanced gastric cancer with 5-fluorouracil and cisplatin in combination with dipyridamole.